Home Healthcare IT Latin America Neurodegenerative Diseases Market Includes Latest Trends, Share, and Foreca

Latin America Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) and By Country(Brazil, Mexico, Argentina, Chile, Colombia, Rest of LATAM) Forecasts, 2022-2030

Report Code: SRHI3194DR
Last Updated : Nov 17, 2022
Author : Straits Research
Starting From
USD 1850
Buy Now

Market Segmentation

  • Latin America Neurodegenerative Disease Market, By Indication Type (2020-2030)
    1. Parkinson's Disease
    2. Alzheimer's Disease
    3. Multiple Sclerosis
    4. Huntington Disease
    5. Amyotrophic Lateral Sclerosis
    6. Spinal Muscular Atrophy (SMA) 
    7. Other Indication Types
  • Latin America Neurodegenerative Disease Market, By Drug Type (2020-2030)
    1. N-methyl-D-aspartate Receptor antagonists
    2. Cholinesterase Inhibitors
    3. Dopamine Agonists
    4. Immunomodulatory Drugs
    5. Acetylcholinesterase (AChE) Inhibitors
    6. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
    7. Catechol-O-Methyltransferase (COMT) Inhibitor
    8. SSRIs
    9. Other Drug Types

    Related Reports

    Global Report
    Regenerative Medicine Market Size The global regenerative medicine market size is estimated to be worth USD 19.80 billion in 2024 and is projected to reach from USD 24.88 billion in 2025 to USD 148.42 billion by 2033, growing at
    Buy Now

    Purchase Benefits

    • Eligible for a free updated report next year
    • Completely customizable scope
    • 30% discount on your next purchase
    • Dedicated account manager
    • Query resolution within 24 hours
    • Permission to print the report


    We are featured on :